| Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis | |
| Wang, Yan; Cheng, Xi; Cui, Yue-hong; Hou, Jun; Ji, Yuan; Sun, Yi-hong; Shen, Zhen-bin; Liu, Feng-lin; Liu, Tian-shu | |
| 刊名 | BMC CANCER
 |
| 2018 | |
| 卷号 | 18 |
| 关键词 | Locally advanced gastric cancer Preoperative chemotherapy Curative resection rate Propensity score matching analysis |
| ISSN号 | 1471-2407 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3604584 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Wang, Yan,Cheng, Xi,Cui, Yue-hong,et al. Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis[J]. BMC CANCER,2018,18. |
| APA | Wang, Yan.,Cheng, Xi.,Cui, Yue-hong.,Hou, Jun.,Ji, Yuan.,...&Liu, Tian-shu.(2018).Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis.BMC CANCER,18. |
| MLA | Wang, Yan,et al."Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis".BMC CANCER 18(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论